Matsuoka Takashi, Suzuki Issei, Suzuki Ryosuke, Fukunaga Arinobu, Tohi Yoichiro, Sugino Yoshio, Okada Takuya, Kawakita Mutsushi
Department of Urology, Kobe City Medical Center General Hospital, 2-1-1 Minatojima- Minamimachi, Chuo-ku, Kobe-shi, Hyogo, 650-0047, Japan.
BMC Surg. 2025 Jun 4;25(1):244. doi: 10.1186/s12893-025-02987-6.
Partial nephrectomy is the gold standard for small renal cell carcinoma (RCC). Robot-assisted partial nephrectomy (RAPN), introduced in 2004, has gained acceptance as a minimally invasive approach. Determining resection margins in complex cases remains a challenge. 5-ALA, a photosensitizer metabolized to protoporphyrin IX (PPIX), induces red fluorescence under blue light, aiding tumor detection. Although effective in other malignancies, its utility in renal tumors is not well established.
Between May 2016 and August 2017, 19 patients underwent RAPN using photodynamic diagnosis (PDD) at our institution with the da Vinci Surgical System Si. Patients received 20 mg/kg 5-ALA in 50 mL water orally, 0-12 h before skin incision. Tumor fluorescence was observed with Olympus or Storz camera systems under excitation wavelengths for characteristic red fluorescence during surgery. We evaluated 5-ALA and protoporphyrin IX (PPIX) levels in tumor and normal tissues by high-performance liquid chromatography (HPLC). Statistical analyses were performed using Mann‒Whitney U tests with GraphPad Prism 5. A p-value of less than 0.05 was considered statistically significant.
Tumor pathology revealed clear cell RCC in 17 and chromophobe RCC in two cases. Only one clear cell RCC tumor showed fluorescence under excitation wavelengths before renal artery clamping; however, normal peri-tumoral tissues also demonstrated fluorescence. In three cases, including this one, fluorescence was observed in both tumor and normal tissues ex vivo within a dark box. In the ex vivo analysis, two cases exhibited fluorescence in the tumor tissue without fluorescence in the normal tissue, while one exhibited the reverse. Accumulation of 5-ALA and PPIX in resected tissue specimens was measured in six cases. Although statistical significance was not reached due to the small sample size (p = 0.057, Mann-Whitney U test), PPIX concentrations tended to be higher in fluorescence-positive tumors than in fluorescence-negative ones.
Both tumors and normal tissues exhibited heterogeneous PPIX levels, limiting margin visualization. While current 5-ALA-PDD was insufficient for guiding resection in RAPN, further optimization may enhance its clinical utility.
部分肾切除术是小肾癌(RCC)的金标准。2004年引入的机器人辅助部分肾切除术(RAPN)已被认可为一种微创方法。在复杂病例中确定切除边缘仍然是一项挑战。5-氨基乙酰丙酸(5-ALA)是一种代谢为原卟啉IX(PPIX)的光敏剂,在蓝光下可诱导红色荧光,有助于肿瘤检测。尽管其在其他恶性肿瘤中有效,但其在肾肿瘤中的效用尚未得到充分证实。
2016年5月至2017年8月期间,19例患者在我院使用达芬奇Si手术系统接受了光动力诊断(PDD)下的RAPN。患者在皮肤切口前0 - 12小时口服20mg/kg 5-ALA溶于50mL水中。手术期间,使用奥林巴斯或史托斯摄像系统在激发波长下观察肿瘤荧光,以获取特征性红色荧光。我们通过高效液相色谱(HPLC)评估肿瘤组织和正常组织中的5-ALA和原卟啉IX(PPIX)水平。使用GraphPad Prism 5软件进行Mann-Whitney U检验进行统计分析。p值小于0.05被认为具有统计学意义。
肿瘤病理显示17例为透明细胞RCC,2例为嫌色细胞RCC。只有1例透明细胞RCC肿瘤在肾动脉夹闭前的激发波长下显示荧光;然而,肿瘤周围正常组织也显示荧光。在包括该病例在内的3例中,在暗盒内离体观察到肿瘤组织和正常组织均有荧光。在离体分析中,2例肿瘤组织有荧光而正常组织无荧光,1例情况相反。对6例切除组织标本中5-ALA和PPIX的积累进行了测量。尽管由于样本量小未达到统计学意义(p = 0.057,Mann-Whitney U检验),但荧光阳性肿瘤中的PPIX浓度往往高于荧光阴性肿瘤。
肿瘤组织和正常组织均表现出PPIX水平的异质性,限制了边缘可视化。虽然目前的5-ALA-PDD在RAPN中指导切除不足,但进一步优化可能会提高其临床效用。